Literature DB >> 8300135

Production and characterization of specific asialoglycoprotein receptor antibodies.

Y Kohgo1, J Kato, R Nakaya, Y Mogi, H Yago, Y Sakai, H Matsushita, Y Niitsu.   

Abstract

Monoclonal antibodies (MoAbs) were produced by immunizing BALB/c mice with asialoglycoprotein receptor (AGPR) purified from human liver. The purity of AGPR was confirmed by SDS-polyacrylamide gel electrophoresis and by amino acid sequence. An enzyme-linked immunoassay revealed 24 monoclonal antibodies which reacted with human AGPR. By Western blot analysis, all antibodies recognized the 46 kDa human AGPR under the non-reduced conditions and four MoAbs recognized reduced protein. Two MoAbs reacted with AGPR derived from rat, rabbit and mouse liver under both non-reduced and reduced conditions, suggesting that we could obtain antibodies which reacted with AGPR epitopes shared by different species. In immunohistochemical studies, 30201-MoAb reacted with human liver tissue but not with other tissues. This antibody immunoprecipitated two major bands of 46 kDa and 39 kDa from [35S]-methionine metabolically labeled human hepatoma HepG2 cells. The determinant recognized by 30201-MoAb is a common epitope of AGPR which is present in different species and in both the precursor and maturation forms of the receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8300135     DOI: 10.1089/hyb.1993.12.591

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  Regulation of asialoglycoprotein receptor synthesis by inflammation-related cytokines in HepG2 cells.

Authors:  R Nakaya; Y Kohgo; Y Mogi; M Nakajima; J Kato; Y Niitsu
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

2.  The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.

Authors:  D Trerè; L Fiume; L B De Giorgi; G Di Stefano; M Migaldi; M Derenzini
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

3.  Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature.

Authors:  Kerstin Baer; Christian Klotz; Stefan H I Kappe; Thomas Schnieder; Ute Frevert
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.